• FirefoxInstall the new Firefox »
  •  Dow Down 1.11% Nasdaq Down 0.94%

    Actavis plc (ACT)

    -NYSE
    297.62 Down 7.14(2.34%) 4:03PM EDT
    |After Hours : 300.80 Up 3.18 (1.07%) 7:59PM EDT
    Add to Portfolio
    Prev Close:304.76
    Open:303.11
    Bid:299.70 x 100
    Ask:303.75 x 100
    1y Target Est:340.90
    Beta:0.84
    Earnings Date:Apr 28 - May 4 (Est.)
    Day's Range:297.62 - 304.80
    52wk Range:184.71 - 317.72
    Volume:3,553,859
    Avg Vol (3m):3,288,830
    Market Cap:79.24B
    P/E (ttm):N/A
    EPS (ttm):-7.42
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Headlines

    » More Headlines for ACT

    Comparison

    Symbol% ChgMkt Cap
    ACTDown 2.34%79.24B
    MYLDown 1.08%22.46B
    NVSDown 2.67%236.53B
    TEVADown 0.35%53.07B

    Key Statistics

    Forward P/E (1 yr):14.01
    P/S (ttm):6.21
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :17.60
    Quarterly EPS Est (Mar-15) :4.03
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):0.96

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Actavis plc develops, manufactures, and sells generic, brand, and biosimilar pharmaceuticals. It offers over-the-counter products. The company also provides biosimilar products in women’s health, oncology, and other therapeutic categories. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback